ACCCBUZZ BLOG

Lung cancer remains the leading cause of cancer-related death in the United States, accounting for more fatalities than colorectal and pancreatic cancer combined. One of the keys to improving clinical outcomes lies in early detection and intervention, especially for incidental lung nodules, which could be an early indicator of lung cancer.

ACCC recognizes August 1st as World Lung Cancer Day through its past Innovator Award winners.

ACCCBuzz spotlights University of Colorado Cancer Center, one of the recipients of the 2024 ACCC Innovator Award.

Highlights from a LUNGevity Lung Cancer Precision Medicine Summit that addressed critical issues surrounding biomarker testing in non-small cell lung cancer.

LUNGevity invited ACCC and other stakeholders across the oncology world to Washington DC, for their second Health Equity Summit on Tuesday, March 12.

ACCC recognizes April as National Cancer Prevention and Early Detection Month.

ACCC's Improving Care Coordination Model can lead to improved care and treatment outcomes for patients with lung cancer.

Insight from 2 ACCC members on the implementation of the Improving Care Coordination Model.

As immune checkpoint inhibitors have become the standard of care for eligible patients with NSCLC, frequent monitoring of irAEs as well as provider and patient education on the signs and symptoms of pneumonitis can ensure improved clinical outcomes for patients.

St. Elizabeth Cancer Center launched a comprehensive program to perform outreach to patients with outstanding orders for lung, breast, and colon cancer screenings.

In 2012, August 1 was declared World Lung Cancer Day—11 years later, its significance is as important as ever.

In the face of an unprecedented drug shortage, HOPA partnered with ACCC and AVAHO to lead a virtual round table discussing best practices the multidisciplinary cancer care team can use to mitigate its effects.

ACCC held a LinkedIn live event on March 13, 2023, with subject matter experts, who shared strategies for tackling lung cancer disparities in the Appalachian Region and beyond.

In recognition of National Cancer Prevention Month, the continued effort toward preventing cancer must be characterized by actions not words.

Every November we remember National Lung Cancer Awareness Month. So ACCCBuzz spoke with Caroline Wolf to learn more about CHI Memorial's lung screening outreach efforts and Breathe Easy Mobile Lung Screening Program.

Care optimization is everything in today’s rapidly changing healthcare landscape. Learn how ACCC's nationwide quality improvement (QI) initiative helped Southern Ohio Medical Center Cancer Center develop and implement plans to support the optimization of care for patients diagnosed with Stages III and IV non-small cell lung cancer (NSCLC).

The COVID-19 pandemic had a significant impact on the cancer screening rate. While telemedicine has facilitated care delivery, there is a need for programs aimed at promoting screening. This understanding prompted Mercy Medical Center-Cedar Rapids, Hall-Perrine Cancer Center in Iowa to launch a initiative that has excelled in increasing their colorectal screening rates, and facilitated the provision of high-quality care in the community.

Communities around the globe recognize August 1 as World Lung Cancer Day—a day to commemorate, educate, and support individuals and families impacted by lung cancer. Read highlights on a few ACCC initiatives that are helping cancer care teams better support their patients with this disease.

In 2020, medical experts warned that COVID-19 could, over time, have a substantial impact on cancer outcomes due to delayed or missed cancer screenings for patients. To obtain a better perspective of how cancer programs’ screening and outreach education efforts are recovering from pandemic pressures, ACCCBuzz spoke to four cancer programs across the country.

Lung cancer is the leading cause of cancer death and the second-most common cancer detected in both men and women in the U.S. Lung cancer accounts for nearly 25% of all cancer deaths in this country. According to estimates by the American Cancer Society, 235,760 patients will be diagnosed with lung cancer, and 131,880 patients will die of the disease in 2021.

In launching its new campaign, Transforming Complex To Clear, ACCC brought together expert panelists to discuss effective practices and offer tips to address current barriers to biomarker testing in the community setting.

August 1 marks World Lung Cancer Day. Long at the forefront of teaching multidisciplinary cancer care teams about how to best implement new and evolving lung cancer therapies into their programs and practices, ACCC shares several of its current initiatives to promote optimal lung cancer care delivery.

Growing knowledge of NSCLC subtypes and molecular biomarkers for this disease has led to changes in how NSCLC is diagnosed and staged.